193 related articles for article (PubMed ID: 8787921)
1. Comparison of fluconazole and amphotericin B for treatment of experimental Candida albicans endocarditis in rabbits.
Chemlal K; Saint-Julien L; Joly V; Farinotti R; Seta N; Yeni P; Carbon C
Antimicrob Agents Chemother; 1996 Jan; 40(1):263-6. PubMed ID: 8787921
[TBL] [Abstract][Full Text] [Related]
2. Efficacies of high-dose fluconazole plus amphotericin B and high-dose fluconazole plus 5-fluorocytosine versus amphotericin B, fluconazole, and 5-fluorocytosine monotherapies in treatment of experimental endocarditis, endophthalmitis, and pyelonephritis due to Candida albicans.
Louie A; Liu W; Miller DA; Sucke AC; Liu QF; Drusano GL; Mayers M; Miller MH
Antimicrob Agents Chemother; 1999 Dec; 43(12):2831-40. PubMed ID: 10582868
[TBL] [Abstract][Full Text] [Related]
3. Comparison of fluconazole and amphotericin B for treatment of experimental Candida endocarditis caused by non-C. albicans strains.
Witt MD; Imhoff T; Li C; Bayer AS
Antimicrob Agents Chemother; 1993 Sep; 37(9):2030-2. PubMed ID: 8239628
[TBL] [Abstract][Full Text] [Related]
4. Impact of the order of initiation of fluconazole and amphotericin B in sequential or combination therapy on killing of Candida albicans in vitro and in a rabbit model of endocarditis and pyelonephritis.
Louie A; Kaw P; Banerjee P; Liu W; Chen G; Miller MH
Antimicrob Agents Chemother; 2001 Feb; 45(2):485-94. PubMed ID: 11158745
[TBL] [Abstract][Full Text] [Related]
5. Comparison of fluconazole and amphotericin B in prophylaxis of experimental Candida endocarditis caused by non-C. albicans strains.
Bayer AS; Witt MD; Kim E; Ghannoum MA
Antimicrob Agents Chemother; 1996 Feb; 40(2):494-6. PubMed ID: 8834908
[TBL] [Abstract][Full Text] [Related]
6. Comparison of fluconazole and amphotericin B for prevention and treatment of experimental Candida endocarditis.
Witt MD; Bayer AS
Antimicrob Agents Chemother; 1991 Dec; 35(12):2481-5. PubMed ID: 1810181
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of fluconazole in prophylaxis and treatment of experimental Candida endocarditis.
Longman LP; Hibbert SA; Martin MV
Rev Infect Dis; 1990; 12 Suppl 3():S294-8. PubMed ID: 2184507
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the efficacy of cilofungin, fluconazole and amphotericin B in the treatment of systemic Candida albicans infection in the neutropenic mouse.
Bannatyne RM; Cheng PC; Fong IW
Infection; 1992; 20(3):168-70. PubMed ID: 1644494
[TBL] [Abstract][Full Text] [Related]
9. Fluconazole plus cyclosporine: a fungicidal combination effective against experimental endocarditis due to Candida albicans.
Marchetti O; Entenza JM; Sanglard D; Bille J; Glauser MP; Moreillon P
Antimicrob Agents Chemother; 2000 Nov; 44(11):2932-8. PubMed ID: 11036003
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility to thrombin-induced platelet microbicidal protein is associated with increased fluconazole efficacy against experimental endocarditis due to Candida albicans.
Yeaman MR; Cheng D; Desai B; Kupferwasser LI; Xiong YQ; Gank KD; Edwards JE; Bayer AS
Antimicrob Agents Chemother; 2004 Aug; 48(8):3051-6. PubMed ID: 15273120
[TBL] [Abstract][Full Text] [Related]
11. Interaction between fluconazole and amphotericin B in mice with systemic infection due to fluconazole-susceptible or -resistant strains of Candida albicans.
Louie A; Banerjee P; Drusano GL; Shayegani M; Miller MH
Antimicrob Agents Chemother; 1999 Dec; 43(12):2841-7. PubMed ID: 10582869
[TBL] [Abstract][Full Text] [Related]
12. Combination therapy with amphotericin B and fluconazole against invasive candidiasis in neutropenic-mouse and infective-endocarditis rabbit models.
Sanati H; Ramos CF; Bayer AS; Ghannoum MA
Antimicrob Agents Chemother; 1997 Jun; 41(6):1345-8. PubMed ID: 9174196
[TBL] [Abstract][Full Text] [Related]
13. Effects of antifungal therapy on inflammation, sterilization, and histology in experimental Candida albicans meningitis.
Jafari HS; Sáez-Llorens X; Severien C; Parras F; Friedland I; Rinderknecht S; Ehrett S; Olsen KD; Abramowsky C; McCracken GH
Antimicrob Agents Chemother; 1994 Jan; 38(1):83-9. PubMed ID: 7511361
[TBL] [Abstract][Full Text] [Related]
14. Successful resolution of cardiac mycetomas by combined liposomal Amphotericin B with Fluconazole treatment in premature neonates.
Karatza AA; Dimitriou G; Marangos M; Christofidou M; Pavlou V; Giannakopoulos I; Darzentas A; Mantagos SP
Eur J Pediatr; 2008 Sep; 167(9):1021-3. PubMed ID: 18205013
[TBL] [Abstract][Full Text] [Related]
15. Candida tropicalis infection in a term neonate with gall bladder masses and infective endocarditis.
Jajoo M; Kumar V; Goyal VK; Garg A
Asian Pac J Trop Med; 2012 May; 5(5):410-2. PubMed ID: 22546661
[TBL] [Abstract][Full Text] [Related]
16. A case of recurrent Candida parapsilosis prosthetic valve endocarditis: cure by medical treatment alone.
Lejko-Zupanc T; Kozelj M
J Infect; 1997 Jul; 35(1):81-2. PubMed ID: 9279731
[TBL] [Abstract][Full Text] [Related]
17. In vitro pharmacodynamics and in vivo efficacy of fluconazole, amphotericin B and caspofungin in a murine infection by Candida lusitaniae.
Sandoval-Denis M; Pastor FJ; Capilla J; Sutton DA; Fothergill AW; Guarro J
Int J Antimicrob Agents; 2014 Feb; 43(2):161-4. PubMed ID: 24360922
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of cilofungin (LY121019) for treatment of experimental Candida albicans endocarditis in rabbits.
Padula A; Chambers HF
Antimicrob Agents Chemother; 1989 Oct; 33(10):1822-3. PubMed ID: 2686548
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of alternative dosing regimens of poly-aggregated amphotericin B.
Espada R; Valdespina S; Molero G; Dea MA; Ballesteros MP; Torrado JJ
Int J Antimicrob Agents; 2008 Jul; 32(1):55-61. PubMed ID: 18534826
[TBL] [Abstract][Full Text] [Related]
20. Successful therapy of Candida albicans arthritis with a sequential intravenous amphotericin B and oral fluconazole regimen.
Barson WJ; Marcon MJ
Pediatr Infect Dis J; 1996 Dec; 15(12):1119-22. PubMed ID: 8970223
[No Abstract] [Full Text] [Related]
[Next] [New Search]
